Amanda Alves de Oliveira

Amanda Alves de Oliveira

Auto-generated profile, based on publicly available information

Amanda Alves de Oliveira

Institute of Tropical Pathology and Public Health, Federal University of Goiás, CEP: 74605-050, Goiânia, Goiás, Brazil

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 November 2020 in Journal of Fungi
Verified
Journal Article
Open access
PDF file
LSLívia do Carmo Silva
Lívia do Carmo Silva
AOAmanda Alves de Oliveira
Amanda Alves de Oliveira
Dienny de SouzaDienny de Souza
Dienny de Souza
KBKatheryne lohany Barros barbosa
Katheryne lohany Barros barbosa
KSKleber Santiago Freitas Silva
Kleber Santiago Freitas Silva
MPMaristela Pereira
Maristela Pereira
Paracoccidioidomycosis is a neglected disease that causes economic and social impacts, mainly affecting people of certain social segments, such as rural workers. The limitations of antifungals, such as toxicity, drug interactions, restricted routes of administration, and the reduced bioavailability in target tissues, have become evident in clinical settings. These factors, added to the fact that Paracoccidioidomycosis (PCM) therapy is a long process, lasting from months to years, emphasize the need for the research and development of new molecules. Researchers have concentrated efforts on the identification of new compounds using numerous tools and targeting important proteins from Paracoccidioides, with the emphasis on enzymatic pathways absent in humans. This review aims to discuss the aspects related to the identification of compounds, methodologies, and perspectives when proposing new antifungal agents against PCM.

20 January 2023 in Future Microbiology
Verified
Journal Article
Closed access
LSLívia do Carmo Silva
Lívia do Carmo Silva
RFRaimundo F dos Santos Filho
Raimundo F dos Santos Filho
AOAmanda A de Oliveira
Amanda A de Oliveira
FMFelipe T Martins
Felipe T Martins
SCSilvio Cunha
Silvio Cunha
MPMaristela Pereira
Maristela Pereira
Aims: Considering the need to identify new compounds with antifungal action, the activity of five 3-phenacylideneoxindoles compounds was evaluated. Materials & methods: The compounds were synthesiz... Plain language summary Patients affected by paracoccidioidomycosis (PCM) require long-term treatment, which commonly influences their adherence. In addition, only three drugs are in clinical use, w...

6 October 2023 in New Journal of Chemistry
Verified
Journal Article
Closed access
PDF file
AOAmanda Alves de Oliveira
Amanda Alves de Oliveira
LSLívia do Carmo Silva
Lívia do Carmo Silva
ARAndrew Matheus Frederico Rozada
Andrew Matheus Frederico Rozada
VCVinícius Alexandre Fiaia Costa
Vinícius Alexandre Fiaia Costa
CSCélia Maria de Almeida Soares
Célia Maria de Almeida Soares
MPMaristela Pereira
Maristela Pereira
Paracoccidioidomycosis (PCM) is a serious system fungal infection that causes significant death and suffering, particularly in Latin America. The treatment of PCM is limited by a few pharmacological options that require long-term administration protocols. Considering the few classes of drugs available for the treatment of PCM and the long time of the treatment, developing new anti-PCM compounds is relevant. With the purpose to develop new 4-methoxynaphthalene-N-acylhydrazone bioisosteres with anti-Paracoccidioides activity, a series of 4-methoxynaphthalene-N-acylhydrazones, which had already been tested against P. brasiliensis, was used to develop shape-based models. The models underwent statistical validation and were used to filter a library of compounds, which were ranked using scoring functions. Molecular docking analysis was used to select 6 compounds that were synthesized and evaluated biologically using minimum inhibitory concentration, minimum fungicidal concentration tests, and cytotoxicity. Using this protocol, we prioritized 6 compounds for synthesis and in vitro biological evaluation. Among them, two compounds (AOS2 and AOS3) were found to exhibit nanomolar activity against two P. brasiliensis isolates and low cytotoxicity for BalbC/3T3 cells (selectivity indexes >2048). The designed and synthesized 4-methoxynaphthalene-N-acylhydrazones could serve as a promising starting point for the development of anti-PCM agents.

20 September 2023 in Future Medicinal Chemistry
Verified
Journal Article
Closed access
AOAmanda Alves de Oliveira
Amanda Alves de Oliveira
LSLívia do Carmo Silva
Lívia do Carmo Silva
BNBruno Neves
Bruno Neves
VCVinícius Alexandre Fiaia Costa
Vinícius Alexandre Fiaia Costa
EMEugene Muratov
Eugene Muratov
MPMaristela Pereira
Maristela Pereira
Aims: The development of safe and effective therapies for treating paracoccidioidomycosis using computational strategies were employed to discover anti-Paracoccidioides compounds. Materials & metho... Graphical abstract